iRadimed IRMD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.37M+10.2% | $51.16M-9.5% | $56.53M+6.7% | $53M+5.3% | $50.33M-3.6% | ||
| $13.42M-1.8% | $13.67M-1.4% | $13.86M+26.9% | $10.92M-14.0% | $12.71M+20.4% | ||
| $12.45M+2.3% | $12.18M+3.8% | $11.73M+4.8% | $11.2M+6.1% | $10.56M+1.5% | ||
| $86.42M+6.4% | $81.2M-4.4% | $84.92M+9.8% | $77.37M+3.0% | $75.14M-0.1% | ||
| $24.23M+1.5% | $23.86M+0.3% | $23.79M+3.7% | $22.94M+12.6% | $20.38M+21.2% | ||
| $3.29M-2.9% | $3.38M+0.3% | $3.37M0.0% | $3.37M+3.6% | $3.26M+5.2% | ||
| $114.39M+5.2% | $108.78M-5.2% | $114.72M+7.8% | $106.45M+4.6% | $101.73M+3.5% | ||
| $2.18M+19.9% | $1.82M-22.0% | $2.33M+22.8% | $1.9M-26.6% | $2.59M+36.6% | ||
| $3.4M+18.3% | $2.87M-9.1% | $3.16M-3.1% | $3.26M+25.4% | $2.6M+15.0% | ||
| $12.12M+19.0% | $10.18M-20.4% | $12.8M+45.2% | $8.81M+4.0% | $8.47M-0.5% | ||
| $15.88M+12.1% | $14.16M-13.5% | $16.37M+34.8% | $12.15M+4.0% | $11.68M+1.5% | ||
| 31.5M0.0% | 31.5M+2,476,315% | 1.3K0.0% | 1.3K0.0% | 1.3K+27.2% | ||
| $67.49M+5.1% | $64.23M-3.2% | $66.34M+5.4% | $62.93M+6.1% | $59.32M+4.4% | ||
| $98.51M+4.1% | $94.62M-3.8% | $98.35M+4.3% | $94.3M+4.7% | $90.05M+3.7% | ||
| $114.39M+5.2% | $108.78M-5.2% | $114.72M+7.8% | $106.45M+4.6% | $101.73M+3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are iRadimed's total assets?
- iRadimed (IRMD) holds $114.4M in total assets, up 12.4% year over year.
- How much cash does iRadimed have?
- iRadimed holds $56.4M in cash and equivalents.
- Can iRadimed cover its short-term obligations?
- Its current ratio is 7.13 — current assets exceed current liabilities.
- Where does iRadimed's balance sheet data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
